Drug Shortage Report for APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE

Last updated on 2017-05-23 History
Report ID 14
Drug Identification Number 02416255
Brand name APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE
Common or Proper name Abacavir-Lamivudine-Zidovudine
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) ZIDOVUDINE ABACAVIR LAMIVUDINE
Strength(s) 300MG 300MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60 BTL
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-02-27
Estimated end date 2017-05-31
Actual end date 2017-05-19
Shortage status Resolved
Updated date 2017-05-23
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2017-05-23 French Compare
v8 2017-05-23 English Compare
v7 2017-05-10 French Compare
v6 2017-05-10 English Compare
v5 2017-04-28 French Compare
v4 2017-04-28 English Compare
v3 2017-03-10 French Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare